Bone and [18F]Fluorodeoxyglucose positron-emission tomography/computed tomography scanning for the assessment of osseous involvement in Hodgkin lymphoma in children and young adults FDG PET/CT & bone scans in pediatric HL B. L. Shulkin et al.

Leukemia and Lymphoma

Volumn 50, Issue 11, 2009, Pages 1794-1802

  Shulkin, Barry L ^a   Goodin, Geoffrey S ^a   McCarville, Mary B ^a   Kaste, Sue C ^a,b   Krasin, Matthew J ^a   Hudson, Melissa M ^a,b   Metzger, Monika ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Bone; FDG; Hodgkin; MDP; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18; MEDRONATE TECHNETIUM TC 99M; DIAGNOSTIC AGENT;

ADULT; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; CANCER DIAGNOSIS; CANCER RELAPSE; CANCER STAGING; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HODGKIN DISEASE; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; ADOLESCENT; BONE; BONE TUMOR; METASTASIS; METHODOLOGY; PATHOLOGY; PROGNOSIS; RADIOGRAPHY; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; BONE AND BONES; BONE NEOPLASMS; CHILD; FEMALE; FLUORODEOXYGLUCOSE F18; HODGKIN DISEASE; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 71049176527     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428190903189027     Document Type: Article

References (25)

1. Shad A, Magrath I. Malignant non-Hodgkin's lymphoma in children. In: Pizzo P, Poplack D, editors. Principles and Practice of Pediatric Oncology, 3rd edn. Philadelphia: Lippincott Raven; 1996. pp 545-587.
2. Hudson MM, Krasin MJ, Kaste SC. PET imaging in pediatric Hodgkin's lymphoma. Pediatr Radiol 2004;34:190-198.
3. Lepanto PB, Rosenstock J, Littman P, et al. Gallium-67 scans in children with solid tumors. AJR Am J Roentgenol 1976;126:179-186.
4. Bekerman C, Hoffer PB, Bitran JD. The role of gallium-67 in the clinical evaluation of cancer. Semin Nucl Med 1984;14:296-323.
5. Tan TX, Gelfand MJ. Ga-67 scintigraphy in pediatric patients. Comparison of extended SPECT of the chest and abdomen with planar imaging. Clin Nucl Med 1996;21:717-719.
6. Orzel JA, Sawaf NW, Richardson ML. Lymphoma of the skeleton: scintigraphic evaluation. AJR Am J Roentgenol. 1988;150:1095-1099.
7. Schechter JP, Jones SE, Woolfenden JM, Lilien DL, O'Mara RE. Bone scanning in lymphoma. Cancer 1976;38:1142-1148.
8. Schwartz CL. The management of Hodgkin disease in the young child. Curr Opin Pediatr 2003;15:10-16.
9. Newman JS, Francis IR, Kaminski MS, Wahl RL. Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy- D-glucose: correlation with CT. Radiology 1994;190:111-116.
10. Bangerter M, Moog F, Buchmann I, et al. Whole-body 2- [18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin's disease. Ann Oncol 1998;9:1117-1122.
11. Hoh CK, Glaspy J, Rosen P, et al. Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma. J Nucl Med 1997;38:343-348.
12. Bar-Shalom R, Mor M, Yefremov N, Goldsmith SJ. The value of Ga-67 scintigraphy and F-18 fluorodeoxyglucose positron emission tomography in staging and monitoring the response of lymphoma to treatment. Semin Nucl Med 2001;31:177-190.
13. Buchmann I, Reinhardt M, Elsner K, et al. 2-(fluorine- 18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial. Cancer 2001;91:889-899.
14. Schoder H, Meta J, Yap C, et al. Effect of whole-body (18)FFDG PET imaging on clinical staging and management of patients with malignant lymphoma. J Nucl Med 2001;42:1139-1143.
15. Montravers F, McNamara D, Landman-Parker J, et al. [(18)F]FDG in childhood lymphoma: clinical utility and impact on management. Eur J Nucl Med Mol Imaging 2002;29:1155-1165.
16. Israel O, Keidar Z, Bar-Shalom R. Positron emission tomography in the evaluation of lymphoma. Semin Nucl Med 2004;34:166-179.
17. Friedberg JW, Fischman A, Neuberg D, et al. FDG-PET is superior to gallium scintigraphy in staging and more sensitive in the follow-up of patients with de novo Hodgkin lymphoma: a blinded comparison. Leuk Lymphoma. 2004;45:85-92.
18. Kostakoglu L, Leonard JP, Kuji I, et al. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma. Cancer 2002;94:879-888.
19. Rini JN, Nunez R, Nichols K, et al. Coincidence-detection FDG-PET versus gallium in children and young adults with newly diagnosed Hodgkin's disease. Pediatr Radiol 2005;35:169-178.
20. Bar-Sever Z, Keidar Z, Ben Barak A, et al. The incremental value of 18F-FDG PET/CT in paediatric malignancies. Eur J Nucl Med Mol Imaging 2007;34:630-637.
21. Goodin GS, Shulkin BL, Kaufman RA, McCarville MB. PET/ CT characterization of fibroosseous defects in children: 18F-FDG uptake can mimic metastatic disease. AJR Am J Roentgenol 2006;187:1124-1128.
22. Ryan PJ, Fogelman I. The bone scan: where are we now? Semin Nucl Med 1995;25:76-91.
23. Mouratidis B, Gilday DL, Ash JM. Comparison of bone and 67Ga scintigraphy in the initial diagnosis of bone involvement in children with malignant lymphoma. Nucl Med Commun 1994;15:144-147.
24. Moog F, Bangerter M, Kotzerke J, et al. 18-F-fluorodeoxyglucose- positron emission tomography as a new approach to detect lymphomatous bone marrow. J Clin Oncol 1998; 16:603-609.
25. Moon TY, Kim EE, Kim YC, et al. Comparison of nuclear bone and gallium scans in the therapeutic evaluation of bone lymphoma. Clin Nuc Med 1995;20: 721-724.